For US Residents
Get access to the support you need in just 2-3 minutes.
See all thatNovartis Patient Supportcan offer:
Icon that looks like a hand holding a wallet
Financial Support
Provide you with financial support options. You could pay as little as $0 with the Co-Pay Plus* offer.
Icon of double shield
Insurance Support
Answer questions about your insurance coverage. We'll help you navigate the process.
Icon of a support person wearing a headset
Ongoing Support
Get useful tips, resources, and reminders throughout your treatment.
If you’d like to sign up on the phone, call 87-RHAPSIDO (877-427-7436), Monday-Friday, 8:00 AM-8:00 PM ET (excluding holidays).
*
Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited toward patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
The Bridge Program applies to RHAPSIDO® only. Eligible patients must have private insurance and a valid prescription for RHAPSIDO, and a delay or denial of coverage. Program requires the submission of a prior authorization or an appeal of the coverage denial within the first 90 days of enrollment to remain eligible. Program provides RHAPSIDO for free to eligible patients for up to 12 months, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Additional limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.
10/25 FA-11441771

IMPORTANT SAFETY INFORMATION

Before taking RHAPSIDO, tell your health care provider about all of your medical conditions, including if you:

  • Have had a recent surgery or plan to have surgery. Your health care provider may tell you to stop taking RHAPSIDO for at least 3 to 7 days before and after any planned medical or surgical procedures
  • Have bleeding problems or are taking a blood thinner medicine
  • Have liver problems
  • Are pregnant or plan to become pregnant. It is not known if RHAPSIDO will harm your unborn baby. If you become pregnant during treatment with RHAPSIDO, talk to your health care provider about registering in the pregnancy exposure registry for RHAPSIDO
  • Are breastfeeding or plan to breastfeed. It is not known if RHAPSIDO passes into your breast milk
  • Have recently received or are scheduled to receive an immunization (vaccine). Talk to your health care provider about receiving any immunizations before taking RHAPSIDO. You should not receive live or live-attenuated vaccines during treatment with RHAPSIDO

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking RHAPSIDO with certain other medications may affect how RHAPSIDO or your other medications work, and can cause side effects.

What are possible side effects of RHAPSIDO?

RHAPSIDO may cause serious side effects, including:

  • Risk of bleeding. Bleeding may happen while being treated with RHAPSIDO. Your health care provider will monitor you for signs and symptoms of bleeding and may stop your treatment if bleeding happens. Your risk of bleeding may increase if you are also taking a blood thinner medicine. Tell your health care provider right away if you get any signs or symptoms of bleeding, such as:
  • Bruising or red or purple skin marks
  • Pink or brown urine
  • Headache, dizziness, confusion, or feeling weak
  • Red or black stools that look like tar

The most common side effects with RHAPSIDO may include nasal congestion, sore throat, and runny nose (nasopharyngitis), bleeding, headache, nausea, and abdominal pain.

These are not all the possible side effects of RHAPSIDO.

Call your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.

Approved Use

What is RHAPSIDO® (remibrutinib)?

RHAPSIDO is a prescription medicine used to treat adults with chronic spontaneous urticaria (CSU) who continue to have symptoms that are not controlled with antihistamine treatment. RHAPSIDO should not be used to treat any other forms of hives (urticaria). It is not known if RHAPSIDO is safe and effective in children.

10/25 FA-11441769